GET3

ATPase GET3 · O43681 · GET3 on Sugi Atlas →

0 patent compounds predicted against GET3, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to GET3 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Pharmacogenomic Evaluation of Antihypertensive Responses PHASE4COMPLETED
Pharmacogenetic Treatment With Anti-Glutaminergic Agents for Comorbid PTSD & AUD PHASE3COMPLETED
Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt) PHASE1/PHASE2RECRUITING
Reverse Transcriptase Inhibitors in AGS PHASE2COMPLETED
Sexually Dimorphic Effects of GHRH in Adult Growth Hormone Testing nanCOMPLETED
Omics Profiling of Weight Loss With Bariatric Surgery nanCOMPLETED
A Patient-tailored Genetic/Biomarker/iPSC Combined Approach in ALS - PERMEALS nanRECRUITING
UW Undiagnosed Genetic Diseases Program nanRECRUITING
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
Genetic Studies in Patients and Families With Infantile Spasms nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Evaluation of Limb-Girdle Muscular Dystrophy nanCOMPLETED
Family Blood Pressure Program - HyperGEN nanCOMPLETED
Family Blood Pressure Program - SAPPHIRe Network nanCOMPLETED
Family Blood Pressure Program - GENOA nanCOMPLETED
Uncovering Genes Behind Cartilage Tumors and Vascular Anomalies Using Genomic Sequencing nanRECRUITING
Targeting Potassium Channels to Reprogram Glioblastoma Microenvironment: in Vitro and in Vivo Studies nanUNKNOWN
Evaluating Response to Vitamin D3 and K2 Supplementation in Healthcare Personnel nanRECRUITING
Family Blood Pressure Program - GenNet Network nanCOMPLETED
Long-term Systematic Follow-up of Patients With Klinefelter Syndrome Followed at the Department of Growth and Reproduction, Rigshospitalet nanENROLLING_BY_INVITATION
Genetic Variation in CLTCL1 and Whole-body Glucose Control nanCOMPLETED
The Molecular Basis of Inherited Reproductive Disorders nanACTIVE_NOT_RECRUITING
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Genetic Analysis of Gray Platelet Syndrome nanCOMPLETED
Genetic Investigation of Cancer Predisposition nanNOT_YET_RECRUITING
Finding Genes With NGS Techniques in Whom Mutations Cause Neurological Diseases nanUNKNOWN
Mechanisms for Individual Differences in Hypertension in Obstructive Sleep nanCOMPLETED
Clinical and Laboratory Study of Methylmalonic Acidemia nanRECRUITING
A Study on Risk Mutations of Vulnerability Genes of Schizophrenia nanUNKNOWN
Whole Genome Sequencing in the Neonatal Intensive Care Unit nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a GET3 binder may also engage these)

ProteinNameSimilarity
O54984 1.000 O54984 →
A5PJI5 1.000 A5PJI5 →
G3V9T7 1.000 G3V9T7 →
Q0IIZ2 0.993 Q0IIZ2 →
Q6IQE5 0.991 Q6IQE5 →
Q6GNQ1 0.988 Q6GNQ1 →
Q9UHW5 0.952 Q9UHW5 →
Q9D3W4 0.950 Q9D3W4 →
Q6R518 0.947 Q6R518 →
Q5RIC0 0.945 Q5RIC0 →
Q0P5E2 0.941 Q0P5E2 →
P20651 0.940 P20651 →
P48453 0.939 P48453 →
Q5HZM6 0.939 Q5HZM6 →
Q6NVL5 0.939 Q6NVL5 →
Q9H9T3 0.938 Q9H9T3 →
P63328 0.938 P63328 →
P48452 0.938 P48452 →
Q2KJ61 0.936 Q2KJ61 →
PPP3CB Serine/threonine protein phosphatase PP2B-alpha catalytic subunit 0.935 landscape →
Q9HB90 0.935 Q9HB90 →
Q503E1 0.935 Q503E1 →
Q9DCR2 0.933 Q9DCR2 →
Q9CZX0 0.933 Q9CZX0 →
PPP3CA Protein phosphatase 3 catalytic subunit alpha 0.933 landscape →
Q5ZHS1 0.933 Q5ZHS1 →
Q99K70 0.933 Q99K70 →
Q9CWS4 0.932 Q9CWS4 →
A4IHW6 0.932 A4IHW6 →
AP3S1 AP-3 complex subunit sigma-1 0.932 landscape →